# Stereotactic Ablative Radiotherapy for the Treatment of Refractory Ventricular Tachycardia

> **NCT05696522** · NA · RECRUITING · sponsor: **Barts & The London NHS Trust** · enrollment: 6 (estimated)

## Conditions studied

- Radiotherapy; Complications
- Ventricular Tachycardia
- Structural Heart Abnormality
- Heart Failure

## Interventions

- **RADIATION:** Stereotactic ablative radiotherapy

## Key facts

- **NCT ID:** NCT05696522
- **Lead sponsor:** Barts & The London NHS Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-12
- **Primary completion:** 2026-05-02
- **Final completion:** 2026-05-02
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05696522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05696522, "Stereotactic Ablative Radiotherapy for the Treatment of Refractory Ventricular Tachycardia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05696522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*